Home › Entities › doctoral_thesis › Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy

Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy

2019 doctoral thesis by Mingtan Tang at University of Auckland
Place doctoral_thesis Q112552695
Press Enter · cited answer in seconds

Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy

Summary

Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy is a doctoral thesis[1].

Key Facts

  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy authored Mono- and Dual-Therapy — author (P50): Mingtan Tang[2].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's instance of is recorded as Mono- and Dual-Therapy — instance of (P31): doctoral thesis[3].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's publisher is recorded as Mono- and Dual-Therapy — publisher (P123): ResearchSpace@Auckland[4].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's copyright license is recorded as Mono- and Dual-Therapy — copyright license (P275): Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand[5].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's country of origin is recorded as Mono- and Dual-Therapy — country of origin (P495): New Zealand[6].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's publication date is recorded as +2019-00-00T00:00:00Z[7].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's main subject is recorded as Mono- and Dual-Therapy — main subject (P921): pharmacy[8].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/49282[9].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's Handle ID is recorded as 2292/49282[10].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's title is recorded as Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy[11].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's copyright holder is recorded as Mono- and Dual-Therapy — copyright holder (P3931): Mingtan Tang[12].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's thesis submitted to is recorded as Mono- and Dual-Therapy — thesis submitted to (P4101): University of Auckland[13].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's on focus list of Wikimedia project is recorded as Mono- and Dual-Therapy — on focus list of Wikimedia project (P5008): NZThesisProject[14].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's copyright status is recorded as Mono- and Dual-Therapy — copyright status (P6216): copyrighted[15].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's online access status is recorded as Mono- and Dual-Therapy — online access status (P6954): open access[16].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's thesis committee member is recorded as Mono- and Dual-Therapy — thesis committee member (P9161): Zimei Wu[17].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's thesis committee member is recorded as Mono- and Dual-Therapy — thesis committee member (P9161): Euphemia Leung[18].
  • Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's thesis committee member is recorded as Mono- and Dual-Therapy — thesis committee member (P9161): Darren Svirskis[19].

Body

Designation and Status

Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy's instance of is recorded as Mono- and Dual-Therapy — instance of (P31): doctoral thesis[3].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [3] ↑ . wikidata.org.
  2. [2] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy. Retrieved May 3, 2026, from https://4ort.xyz/entity/investigation-of-hyaluronic-acid-functionalised-ph-sensitive-liposomes-to-overcome-gemcitabine-resistance-in-pancreatic-cancer-mono-and-dual-therapy
MLA “Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/investigation-of-hyaluronic-acid-functionalised-ph-sensitive-liposomes-to-overcome-gemcitabine-resistance-in-pancreatic-cancer-mono-and-dual-therapy.
BibTeX @misc{4ortxyz_investigation-of-hyaluronic-acid-functionalised-ph-sensitive-liposomes-to-overcome-gemcitabine-resistance-in-pancreatic-cancer-mono-and-dual-therapy_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy}}, year = {2026}, url = {https://4ort.xyz/entity/investigation-of-hyaluronic-acid-functionalised-ph-sensitive-liposomes-to-overcome-gemcitabine-resistance-in-pancreatic-cancer-mono-and-dual-therapy}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy — https://4ort.xyz/entity/investigation-of-hyaluronic-acid-functionalised-ph-sensitive-liposomes-to-overcome-gemcitabine-resistance-in-pancreatic-cancer-mono-and-dual-therapy (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/investigation-of-hyaluronic-acid-functionalised-ph-sensitive-liposomes-to-overcome-gemcitabine-resistance-in-pancreatic-cancer-mono-and-dual-therapy · Last refreshed: